» Articles » PMID: 39234430

A Longitudinal Examination of Blood Sugar Dynamics in Diabetes and Non-Diabetes Using Growth Curve Model: The Sabzevar Persian Cohort Study

Overview
Journal Adv Biomed Res
Date 2024 Sep 5
PMID 39234430
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes mellitus is a chronic metabolic disorder with substantial implications for public health. Understanding the factors influencing blood sugar fluctuations is crucial for effective diabetes management and prevention. This study aimed to evaluate factors associated with blood sugar changes in diabetic patients and healthy individuals attending the Sabzevar Persian Cohort Center, employing the growth curve model.

Materials And Methods: Data related to 589 diabetic patients and 589 non-diabetic patients participating in the Persian cohort study of Sabzevar were used. Due to the repetition of blood sugar measurements for each individual over time, we use the conditional latent growth curve model to examine intra-individual changes and variables that affect these changes over time.

Results: The linear latent growth curve model, fitted with independent variables, exhibited a superior fit. The slope of the line for the diabetic group was measured at 1.78, while for the non-diabetic group, it was estimated to be -0.29. Within the diabetic group, the influence of age, the presence of fatty liver, and history of congenital heart disease (CHD) had a significant impact on the baseline (the intercept), and the effect of body mass index (BMI) on the changing trend of the response variable (slope) was also significant. In the non-diabetic group, significant effects were observed for age variables, BMI, family history of diabetes, and history of stroke in the family.

Conclusion: Overall, the linear latent growth curve model showed good performance in the evaluation of the factors related to blood sugar changes in diabetic patients and healthy people.

References
1.
Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

2.
Ahmadi A, Shirani M, Khaledifar A, Hashemzadeh M, Solati K, Kheiri S . Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study. BMC Public Health. 2021; 21(1):2275. PMC: 8670056. DOI: 10.1186/s12889-021-12326-y. View

3.
Kesavadev J, Misra A, Saboo B, Aravind S, Hussain A, Czupryniak L . Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization. Diabetes Metab Syndr. 2021; 15(1):221-227. PMC: 8049470. DOI: 10.1016/j.dsx.2020.12.032. View

4.
Ciarambino T, Crispino P, Leto G, Mastrolorenzo E, Para O, Giordano M . Influence of Gender in Diabetes Mellitus and Its Complication. Int J Mol Sci. 2022; 23(16). PMC: 9408508. DOI: 10.3390/ijms23168850. View

5.
Ismail L, Materwala H, Al Kaabi J . Association of risk factors with type 2 diabetes: A systematic review. Comput Struct Biotechnol J. 2021; 19:1759-1785. PMC: 8050730. DOI: 10.1016/j.csbj.2021.03.003. View